The mitochondrial ROS and ROS produced by NADPH oxidase-2 (NOX2), known to be activated by viral infection [40], can further lead to fibrosis and platelet aggregation [13], suggesting a potential role for NOX2 inhibitors in long COVID [16,41]. This evidence concerns the gene CYBB and viral infectious disease.